Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo

Oral squamous cell carcinoma is one of the most common neoplasm in the world. Despite the improvements in diagnosis and treatment, the outcome is still poor now. Thus, the development of novel therapeuticapproaches is needed. The aim of this study is to assess the synergistic anti-tumor effect of an...

Full description

Saved in:
Bibliographic Details
Main Authors: Songjie Chen, Hui Hu, Shushu Miao, Jiayong Zheng, Zhijian Xie, Hui Zhao
Format: Article
Language:English
Published: SAGE Publishing 2017-04-01
Series:Tumor Biology
Online Access:https://doi.org/10.1177/1010428317705330
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849710811071643648
author Songjie Chen
Hui Hu
Shushu Miao
Jiayong Zheng
Zhijian Xie
Hui Zhao
author_facet Songjie Chen
Hui Hu
Shushu Miao
Jiayong Zheng
Zhijian Xie
Hui Zhao
author_sort Songjie Chen
collection DOAJ
description Oral squamous cell carcinoma is one of the most common neoplasm in the world. Despite the improvements in diagnosis and treatment, the outcome is still poor now. Thus, the development of novel therapeuticapproaches is needed. The aim of this study is to assess the synergistic anti-tumor effect of andrographolide with cisplatin (DDP) in oral squamous cell carcinoma CAL-27 cells in vitro and in vivo. We performed Cell Counting Kit-8 proliferation assay, apoptosis assay, and western blotting on CAL-27 cells treated with andrographolide, DDP or the combination in vitro. In vivo, we also treated CAL-27 xenografts with andrographolide or the combination, and performed terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling assay and immunohistochemical analysis of Ki-67. The results showed the combination of andrographolide and DDP synergistically inhibited CAL-27 cell proliferation in vitro and caused tumor regression in vivo in the CAL-27 xenografts. In addition, the synergistic anti-tumor effect of andrographolide with synergistic was due to an enhanced apoptosis. Moreover, the combination therapy upregulated the expression level of p-p53 in vitro and decreased Ki-67 expression in vivo. Our data indicate that the combination treatment of andrographolide and DDP results in synergistic anti-tumor growth activity against oral squamous cell carcinoma CAL-27 in vitro and in vivo. These results demonstrated that combination of andrographolide with DDP was likely to represent a potential therapeutic strategy for oral squamous cell carcinoma.
format Article
id doaj-art-43510ab8f3f5457582e2eccb92aab4d2
institution DOAJ
issn 1423-0380
language English
publishDate 2017-04-01
publisher SAGE Publishing
record_format Article
series Tumor Biology
spelling doaj-art-43510ab8f3f5457582e2eccb92aab4d22025-08-20T03:14:47ZengSAGE PublishingTumor Biology1423-03802017-04-013910.1177/1010428317705330Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivoSongjie Chen0Hui Hu1Shushu Miao2Jiayong Zheng3Zhijian Xie4Hui Zhao5Department of Stomatology, Wenzhou People’s Hospital, Wenzhou, ChinaDepartment of Stomatology, Wenzhou People’s Hospital, Wenzhou, ChinaDepartment of Stomatology, Wenzhou People’s Hospital, Wenzhou, ChinaDepartment of Stomatology, Wenzhou People’s Hospital, Wenzhou, ChinaOral and Maxillofacial Surgery, Affiliated Hospital for Stomatology of Zhejiang University School of Medicine, Hangzhou, ChinaDepartment of Stomatology, Wenzhou People’s Hospital, Wenzhou, ChinaOral squamous cell carcinoma is one of the most common neoplasm in the world. Despite the improvements in diagnosis and treatment, the outcome is still poor now. Thus, the development of novel therapeuticapproaches is needed. The aim of this study is to assess the synergistic anti-tumor effect of andrographolide with cisplatin (DDP) in oral squamous cell carcinoma CAL-27 cells in vitro and in vivo. We performed Cell Counting Kit-8 proliferation assay, apoptosis assay, and western blotting on CAL-27 cells treated with andrographolide, DDP or the combination in vitro. In vivo, we also treated CAL-27 xenografts with andrographolide or the combination, and performed terminal deoxynucleotidyl transferase–mediated deoxyuridine triphosphate nick-end labeling assay and immunohistochemical analysis of Ki-67. The results showed the combination of andrographolide and DDP synergistically inhibited CAL-27 cell proliferation in vitro and caused tumor regression in vivo in the CAL-27 xenografts. In addition, the synergistic anti-tumor effect of andrographolide with synergistic was due to an enhanced apoptosis. Moreover, the combination therapy upregulated the expression level of p-p53 in vitro and decreased Ki-67 expression in vivo. Our data indicate that the combination treatment of andrographolide and DDP results in synergistic anti-tumor growth activity against oral squamous cell carcinoma CAL-27 in vitro and in vivo. These results demonstrated that combination of andrographolide with DDP was likely to represent a potential therapeutic strategy for oral squamous cell carcinoma.https://doi.org/10.1177/1010428317705330
spellingShingle Songjie Chen
Hui Hu
Shushu Miao
Jiayong Zheng
Zhijian Xie
Hui Zhao
Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo
Tumor Biology
title Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo
title_full Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo
title_fullStr Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo
title_full_unstemmed Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo
title_short Anti-tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho-p53 in vitro and in vivo
title_sort anti tumor effect of cisplatin in human oral squamous cell carcinoma was enhanced by andrographolide via upregulation of phospho p53 in vitro and in vivo
url https://doi.org/10.1177/1010428317705330
work_keys_str_mv AT songjiechen antitumoreffectofcisplatininhumanoralsquamouscellcarcinomawasenhancedbyandrographolideviaupregulationofphosphop53invitroandinvivo
AT huihu antitumoreffectofcisplatininhumanoralsquamouscellcarcinomawasenhancedbyandrographolideviaupregulationofphosphop53invitroandinvivo
AT shushumiao antitumoreffectofcisplatininhumanoralsquamouscellcarcinomawasenhancedbyandrographolideviaupregulationofphosphop53invitroandinvivo
AT jiayongzheng antitumoreffectofcisplatininhumanoralsquamouscellcarcinomawasenhancedbyandrographolideviaupregulationofphosphop53invitroandinvivo
AT zhijianxie antitumoreffectofcisplatininhumanoralsquamouscellcarcinomawasenhancedbyandrographolideviaupregulationofphosphop53invitroandinvivo
AT huizhao antitumoreffectofcisplatininhumanoralsquamouscellcarcinomawasenhancedbyandrographolideviaupregulationofphosphop53invitroandinvivo